Abstract
Background
Although brain natriuretic peptide (BNP) concentration has been associated with atherosclerosis
and ischemic cardiovascular diseases (CVD) in the general population, less is known
about this relationship in pre-dialysis chronic kidney disease (CKD) patients.
Methods
We prospectively analyzed 227 pre-dialysis patients with CKD [median estimated glomerular
filtration rate (eGFR): 28.82 (11.65–48.20) ml/min/1.73 m2]. At enrollment, BNP concentrations, biochemical and echocardiographic parameters
were measured, and carotid artery ultrasound was performed. Patients were prospectively
followed for a mean 31.8 months (range 0.5–57.0 months). Ischemic CV events and patient outcomes were recorded.
Results
Median BNP concentration at enrollment was significantly higher in the CKD patients
than in a control group [53.9 (16.2–181.0) pg/ml vs. 9.4 (7.0–15.3) pg/ml, P<0.01]. BNP concentration was positively related with the carotid intima–media thickness
of the common carotid artery (CCA-IMT) and left ventricular mass index (LVMI) and
was significantly higher in patients with than without carotid plaques (P<0.01). Logistic regression analysis confirmed that lgBNP concentration was independently
correlated with carotid plaques. Thirty-two patients experienced ischemic cardiovascular
(ICV) events during follow-up. Kaplan–Meier analysis showed that cumulative survival
without new ICV events was better in patients with lower than with higher BNP concentrations
(P<0.01). Cox regression analysis showed that BNP was an independent risk factor for
ICV events (HR=3.167, 95%CI=1.398–7.171, P<0.01).
Conclusions
Similar to findings in the general population, elevated BNP level is related to atherosclerosis
and an increased risk of ICV events in pre-dialytic CKD patients.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of Internal MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease–a cross-sectional study of predialysis, dialysis and kidney-transplantation patients.Atherosclerosis. 2011; 216: 446-451
- Malnutrition–inflammation–atherosclerosis syndrome in patients with end-stage renal disease.J Ren Care. 2011; 37: 12-15
- Role of oxidative stress and indoxyl sulfate in progression of cardiovascular disease in chronic kidney disease.Ther Apher Dial. 2011; 15: 125-128
- Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities.Am Heart J. 2009; 158: 133-140
- Brain natriuretic peptide as a marker of left ventricular hypertrophy in patients with aortic stenosis.J Heart Valve Dis. 2008; 17: 598-605
- Screening the population for left ventricular hypertrophy and left ventricular systolic dysfunction using natriuretic peptides: results from the Dallas Heart Study.Am Heart J. 2009; 157: 746-753
- B-type natriuretic peptide: perioperative patterns in congenital heart disease.Congenit Heart Dis. 2010; 5: 243-255
- Brain natriuretic peptides as biomarkers for atherosclerosis.Prev Cardiol. 2008; 11: 172-176
- Changes in B-type natriuretic peptide levels in hemodialysis and the effect of depressed left ventricular function.Adv Chronic Kidney Dis. 2005; 12: 117-124
- Diagnostic and prognostic value of plasma brain natriuretic peptide in non-dialysis-dependent CRF.Am J Kidney Dis. 2004; 44: 420-428
- B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: relationship to renal function and left ventricular hypertrophy.Am J Kidney Dis. 2005; 46: 610-620
- Diagnostic potential of circulating natriuretic peptides in chronic kidney disease.Nephrol Dial Transplant. 2006; 21: 402-410
- B-type natriuretic peptide concentrations predict the progression of nondiabetic chronic kidney disease: the Mild-to-Moderate Kidney Disease Study.Clin Chem. 2007; 53: 1264-1272
- Elevated brain natriuretic peptide is associated with abnormal heart geometry in children with chronic kidney disease.Kidney Blood Press Res. 2010; 33: 87-93
- Changes in common carotid artery intima–media thickness over 1 year in patients on peritoneal dialysis.Nephrol Dial Transplant. 2005; 20: 404-412
- The impact of B-type natriuretic peptide levels on the diagnoses and management of congestive heart failure.Curr Opin Cardiol. 2002; 17: 340-345
- The value of cardiopulmonary exercise testing and brain natriuretic peptide plasma levels in predicting the prognosis of patients with chronic heart failure.Eur J Intern Med. 2006; 17: 96-101
- Current perspectives on diagnosis of heart failure in long-term dialysis patients.Am J Kidney Dis. 2011; 57: 308-319
- Predictive role of BNP and NT-proBNP in hemodialysis patients.Nephron Clin Pract. 2008; 110: c178-c184
- Predictive value of plasma B-type natriuretic peptide for ischemic stroke: a community-based longitudinal study.Atherosclerosis. 2009; 207: 298-303
- N-terminal pro-B-type natriuretic peptide for predicting coronary disease and left ventricular hypertrophy in asymptomatic CKD not requiring dialysis.Am J Kidney Dis. 2005; 46: 35-44
- N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients.Am J Cardiol. 2006; 97: 1530-1534
- Carotid atherosclerosis and arterial peripheral pulse wave velocity in cerebral thrombosis.J Clin Neurosci. 2006; 13: 45-49
- Increased atherosclerosis and smooth muscle cell hypertrophy in natriuretic peptide receptor A−/−apolipoprotein E−/− mice.Arterioscler Thromb Vasc Biol. 2003; 23: 1077-1082
- Natriuretic peptide system gene expression in human coronary arteries.J Histochem Cytochem. 2002; 50: 799-809
- Effect of natriuretic peptide family on the oxidized LDL-induced migration of human coronary artery smooth muscle cells.Circ Res. 1997; 81: 585-590
- Effects of BNP preconditioning on myocardial cell apoptosis and expressions of bcl-2 and Bax during myocardial ischemia-reperfusion injury in rats.Zhonghua Yi Xue Za Zhi. 2010; 90: 3431-3434
- A slightly elevated level of N-terminal pro-brain natriuretic peptide can predict coronary artery disease in a population with normal left ventricular function.Heart Vessels. 2011; 26: 473-479
- Impact of hemoglobin concentration on plasma B-type natriuretic peptide level and left ventricle echocardiographics characteristics in chronic kidney disease patients.Coll Antropol. 2009; 33: 141-144
- Body mass and atherogenic dyslipidemia as major determinants of blood levels of B-type natriuretic peptides in Arab subjects with acute coronary syndromes.Metab Syndr Relat Disord. 2009; 7: 563-569
- Value of plasma B type natriuretic peptide measurement for heart disease screening in a Japanese population.Heart. 2002; 87: 131-135
- Plasma B-type natriuretic peptide measurement in a multiphasic health screening program.Cardiology. 1998; 90: 89-94
- Clinical significance of B-type natriuretic peptide in the assessment of untreated hypertension.Circ J. 2008; 72: 770-777
Article info
Publication history
Published online: June 26, 2012
Accepted:
June 4,
2012
Received in revised form:
May 13,
2012
Received:
January 10,
2012
Identification
Copyright
© 2012 European Federation of Internal Medicine. Published by Elsevier Inc. All rights reserved.
